---
title: "BeOne Medicines drops 3% in premarket"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306246352.md"
description: "BeOne Medicines fell 2.59% to US$389.33. Down 6.40% over five sessions and up 28.15% YTD."
datetime: "2026-11-20T09:02:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306246352.md)
  - [en](https://longbridge.com/en/news/306246352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306246352.md)
generator: "portal-rs"
---

# BeOne Medicines drops 3% in premarket

BeOne Medicines (ONC.US) declined nearly **3%** in premarket trading to **$389.33**.

The stock is down 6.40% over the past five sessions and up 28.15% year to date.

The Nasdaq Composite is down 5.86% over the past five sessions and up 2.74% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)

## Related News & Research

- [BeOne Medicines: Five solid-tumor programs advance as strong cash flow funds continued pipeline investment](https://longbridge.com/en/news/305810947.md)
- [Why BeOne Medicines Stock Is In Focus After Earnings Beat And Raised Guidance](https://longbridge.com/en/news/304730912.md)
- [Cipher Digital Hovers Near Flatline After Anthropic's $83 IPO Pricing](https://longbridge.com/en/news/306148104.md)
- [BeOne stock breaks out with visions of 177% earnings growth. This telltale clue bodes well.](https://longbridge.com/en/news/302773305.md)
- [ANALYSIS-Anthropic listing extends Nasdaq's dominant run against arch-rival NYSE](https://longbridge.com/en/news/306184666.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**